Dr. M-J Milloy is an infectious disease epidemiologist and a post-doctoral fellow in the Department of Family Practice, Faculty of Medicine at the University of British Columbia (UBC). He is conducting a Michael Smith Foundation for Health Research supported study of factors facilitating optimal clinical outcomes for Aboriginal people who use illicit drugs and are living with HIV/AIDS. This work is supervised by Drs. Thomas Kerr, an assistant professor in the Division of AIDS at UBC and Dr. Evan Adams at the First Nations Health Authority. Milloy is also the co-PI of the ACCESS study, an ongoing NIH-funded observational prospective cohort of people who use illicit drugs and are living with HIV/AIDS in Vancouver's Downtown Eastside.
The author of over 40 peer-reviewed publications since 2008, Milloy's work has been published in top-ranking journals including The Lancet, PLoS ONE, Addiction, the Journal of Infectious Diseases, the Canadian Medical Association Journal, and has been presented at top international scientific meetings. Using quantitative social and clinical epidemiologic methods, his research focuses on the social and structural factors that shape HIV disease progression.
University: University of British Columbia
Department: Family Practice
Position: Post-Doctoral Fellow
Research Location: BC Centre for Excellence in HIV/AIDS; St. Paul's Hospital
Milloy MJ, Marshall BD, Montaner J, Wood E. Housing status and the health of people living with HIV/AIDS. Curr HIV/AIDS Rep. 2012 Dec;9(4):364-74. doi: 10.1007/s11904-012-0137-5. (PubMed abstract)
Milloy MJ, Marshall BD, Kerr T, Buxton J, Rhodes T, Montaner J, Wood E. Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review. AIDS. 2012 Jun 1;26(9):1049-63. doi: 10.1097/QAD.0b013e32835221cc. (PubMed abstract)
Milloy MJ, Kerr T, Buxton J, Rhodes T, Krusi A, Guillemi S, Hogg R, Montaner J, Wood E. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):393-9. doi: 10.1097/QAI.0b013e3182433288. (PubMed abstract)
Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011 Apr 23;377(9775):1429-37. doi: 10.1016/S0140-6736(10)62353-7. Epub 2011 Apr 15. (PubMed abstract)
Milloy MJ, Wood E. Transmitted antiretroviral-resistant HIV: a coming anarchy? Lancet Infect Dis. 2011 May;11(5):336-7. doi: 10.1016/S1473-3099(11)70068-8. (PubMed abstract)